(Q44430989)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Targeting the endocannabinoid system in the treatment of fragile X syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

main subject

endocannabinoid system

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Carlos Matute

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Mara Dierssen Sotos

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Arnau Busquets-Garcia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Antoni Pastor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Susana Mato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

Alberto Luis Perez Samartin

27 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Rafael de la Torre

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Andrés Ozaita

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

11

Rafael Maldonado

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

2

Maria Gomis-González

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Thomas Guegan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

31 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

603-607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23542787%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm.3127

27 February 2020

exact match

0 references

cites work

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

1 reference

FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism

21 January 2018

1 reference

The mGluR theory of fragile X mental retardation

21 January 2018

1 reference

Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.

21 January 2018

1 reference

Dysregulation of mTOR signaling in fragile X syndrome

21 January 2018

1 reference

Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome

21 January 2018

1 reference

Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice

21 January 2018

1 reference

Endocannabinoid-mediated control of synaptic transmission

21 January 2018

1 reference

Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome

21 January 2018

1 reference

Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA.

21 January 2018

1 reference

Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome

21 January 2018

1 reference

The pathophysiology of fragile x syndrome.

21 January 2018

1 reference

The GABAA receptor: a novel target for treatment of fragile X?

21 January 2018

1 reference

Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.

21 January 2018

1 reference

Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses.

21 January 2018

1 reference

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids

21 January 2018

1 reference

mTOR signaling: at the crossroads of plasticity, memory and disease

21 January 2018

1 reference

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling

21 January 2018

1 reference

Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions.

21 January 2018

1 reference

Making synaptic plasticity and memory last: mechanisms of translational regulation

21 January 2018

1 reference

Deregulated mTOR-mediated translation in intellectual disability

21 January 2018

1 reference

The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum

21 January 2018

1 reference

Differential sensitivity of GABA A receptor-mediated IPSCs to cannabinoids in hippocampal slices from adolescent and adult rats

21 January 2018

1 reference

The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome

21 January 2018

1 reference

Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR

21 January 2018

1 reference

The endocannabinoid system and pain

21 January 2018

1 reference

Fragile X mice develop sensory hyperreactivity to auditory stimuli

21 January 2018

1 reference

Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.

21 January 2018

1 reference

Operant behavior to obtain palatable food modifies neuronal plasticity in the brain reward circuit.

21 January 2018

1 reference

Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120.

21 January 2018

1 reference

21 January 2018

The fragile X syndrome

1 reference

12 December 2020

Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium

1 reference

12 December 2020

Dissociation of the pharmacological effects of THC by mTOR blockade

1 reference

12 December 2020

Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus.

1 reference

12 December 2020